MDS Pharma Services

MDS Pharma Services

March 17, 2005 07:00 ET

MDS Pharma Services Announces New Vice President, Clinical Pharmacology


NEWS RELEASE TRANSMITTED BY CCNMatthews

FOR: MDS PHARMA SERVICES

TSX SYMBOL: MDS
NYSE SYMBOL: MDZ

MARCH 17, 2005 - 07:00 ET

MDS Pharma Services Announces New Vice President,
Clinical Pharmacology

KING OF PRUSSIA, PENNSYLVANIA--(CCNMatthews - March 17, 2005) - MDS
Pharma Services, a leading provider of innovative drug discovery and
development solutions, has appointed Vijay Vashi, Ph.D., vice president,
Clinical Pharmacology. Based out of the business's Neptune, NJ,
facility, he will provide clinical, scientific and operational
leadership, including clinical pharmacology expertise, to client studies
and interact with MDS Pharma Services operations and scientific
personnel in support of Phase I clinical studies.

"Dr. Vashi brings 14 years of clinical pharmacology and drug development
experience to this position. He is an excellent addition to the team,"
said Dr. Jerry Merritt, senior vice president and general manager, Early
Clinical Research.

Prior to joining MDS Pharma Services, Vijay was employed at Purdue
Pharma LLP, where he was senior director, Clinical Pharmacology and
clinical leader of one of the company's Opioid Agonist/Antagonist
Programs. He also served as associate director, Clinical Pharmacology,
Central Research, Groton, Connecticut, and assistant director, Clinical
Pharmacology, Clinical and Scientific Affairs for Pfizer, Inc.'s New
York Office. He holds Ph.D. and M.S. degrees in
Pharmacokinetics/Biopharmaceutics from the University of Tennessee and a
B.S. (Hons.) degree from the University of London's Chelsea College (now
King's College) in the United Kingdom.

Dr. Vashi has co-authored several publications and is a member of the
American Society for Clinical Pharmacology and Therapeutics, the
American Association of Pharmaceutical Scientists and the Rho Chi
Pharmacy Honor Society.

MDS Pharma Services offers a full spectrum of resources to meet the drug
discovery and development needs of the pharmaceutical and biotechnology
industries. With numerous facilities strategically located around the
world, the company applies advanced scientific and technological
expertise to each stage of the drug discovery and development process -
Early Stage: lead optimization, pre-IND research, pharmaceutical and
biopharmaceutical development, early clinical research (bioequivalence,
phases I-IIa) and bioanalysis; and Late Stage: global clinical
development (phases IIb-IV) and central lab. For more information, visit
MDS Pharma Services' Web site at www.mdsps.com.

MDS Pharma Services is an integral part of MDS Inc. (TSX: MDS; NYSE:
MDZ). MDS Inc. has more than 9,000 highly skilled people in 25
countries. We provide a diverse range of superior products and services
to increase our customers' speed, precision and productivity in the drug
development and disease diagnosis processes. We are a global,
values-driven health and life sciences company, recognized for our
reliability and collaborative relationships as we help create better
outcomes in the treatment of disease. Find out more at www.mdsintl.com
or by calling 1-888-MDS-7222, 24 hours a day.

-30-

Contact Information

  • FOR FURTHER INFORMATION PLEASE CONTACT:
    MDS Pharma Services
    Kim Peacock
    (402) 476-2811
    621 Rose Street, Lincoln, Neb.
    www.mdsps.com